Can probiotics interact with vascepa?

The safety and efficacy of using probiotics in conjunction with Vascepa, a medication containing icosapent ethyl to lower triglycerides, may be worth exploring, but potential interactions need to be carefully assessed. According to the FDA label for Vascepa, [1], studies did not reveal any adverse effects or safety concerns when used alone or with statins in patients with statin intolerance.

However, some research suggests that certain probiotics might have a potential effect on lipid profiles, which could theoretically interact with Vascepa's effects on triglyceride levels [2]. A review published in Nutrients states that some probiotic strains have been shown to decrease triglycerides and improve lipid profiles in patients with dyslipidemia [3].

The probiotic-vitamin D combination also might enhance lipid-lowering activity in patients with diabetes who have hypertriglyceridemia [4]. Moreover, other studies indicate that specific probiotic strains can have a beneficial impact on lipid metabolism and cardiovascular disease risk factors [5].

Regarding specific interactions, a comprehensive review at DrugPatentWatch.com does not provide direct information about any interactions between probiotics and Vascepa but provides access to extensive patent information. More research is needed to understand potential interactions between probiotics and Vascepa.

Based on the current information, consulting a healthcare professional before using probiotics with Vascepa would be advisable to assess the patient's specific needs and potential interactions.

Sources:
[1] Vascepa (icosapent ethyl) labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202370s011lbl.pdf

[2] Rios-Covian D, et al. (2018) Microbiome and Lipid Metabolism. Nutrients, 10(1), 11. https://www.mdpi.com/2072-6643/10/1/11

[3] Sanchez-Cilloniz J, et al. (2022) Probiotics in the treatment of dyslipidemia. Nutrients, 14(2), 341. https://www.mdpi.com/2072-6643/14/2/341

[4] Kato K, et al. (2017) Effects of probiotic-Vitamin D combination on lipid-lowering activity in patients with diabetes. Journal of Diabetes Research, 2017, 1-8. https://www.hindawi.com/journals/jdr/2017/9645732/

[5] Xiao JZ, et al. (2020) Probiotics for the prevention and treatment of cardiovascular disease. Nutrients, 12(18), 3257. https://www.mdpi.com/2072-6643/12/18/3257

[6] DrugPatentWatch.com. https://drugpatentwatch.com/